INHIBITION OF MAMMALIAN DNA POLYMERASE-ASSOCIATED 3' TO 5' EXONUCLEASE ACTIVITY BY 5'-MONOPHOSPHATES OF 3'-AZIDO-3'-DEOXYTHYMIDINE AND 3'-AMINO-3'-DEOXYTHYMIDINE
Eg. Bridges et al., INHIBITION OF MAMMALIAN DNA POLYMERASE-ASSOCIATED 3' TO 5' EXONUCLEASE ACTIVITY BY 5'-MONOPHOSPHATES OF 3'-AZIDO-3'-DEOXYTHYMIDINE AND 3'-AMINO-3'-DEOXYTHYMIDINE, Biochemical pharmacology, 45(8), 1993, pp. 1571-1576
3'-Azido-3'-deoxythymidine 5'-monophosphate (AZT-MP) has been hypothes
ized by us to possibly affect 3'-azido-3'-deoxythymidine (AZT) excisio
n from host cell DNA. In the present study, AZT-MP inhibited 3' to 5'
exonuclease activity of calf thymus DNA polymerase delta at pharmacolo
gical relevant intracellular concentrations. Other 2',3'-dideoxynucleo
side-5'-monophosphate (ddN-MP) analogs, including 3'-amino-3'-deoxythy
midine-5'-monophosphate (AMT-MP), were also assayed as potential inhib
itors of 3' to 5' exonuclease activity. Tle monophosphate derivative o
f 3'-amino-3'-deoxythymidine (AMT), an in vivo toxic catabolite of AZT
, was the most potent of the ddN-MP analogs tested, inhibiting this ac
tivity by more than 50% at 100 muM. These results suggest that inhibit
ion of 3' to 5' exonuclease activities by AZT-MP and AMT-MP may increa
se steady-state levels of AZT in host DNA, accounting in part for the
cell toxicity associated with this drug. The present study also raises
the question of whether AZT-MP inhibition of this activity may lead t
o potential mutagenic effects due to inhibition of 3' to 5' exonucleas
e-mediated proofreading functions involved in DNA replication.